Breast cancer, Kidney cancer, Lung cancer, Non small cell lung cancer (NSCLC), Renal cell cancer, Secondary cancers
Open
Phase 2
This trial is looking at adding a drug called celecoxib to standard treatment to improve treatment for advanced cancer. This is cancer that has spread into surrounding tissues or to another part of the body.
It is for people who are having their first treatment for advanced:
triple negative breast cancer
non small cell lung cancer
renal cell cancer
Recruitment start: 8 May 2024
Recruitment end: 1 December 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Anne Armstrong
The Christie NHS Foundation Trust
The Jon Moulton Charity Trust
The Christie Charity
Liverpool Clinical Trials Centre
Last reviewed: 15 Apr 2025
CRUK internal database number: 19932
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
